Parmax Pharma postpones board meeting to November 14th to address unforeseen circumstances Back
<p>Parmax Pharma Limited informed the Bombay Stock Exchange that the board meeting scheduled for Friday, November 13, 2026, to approve unaudited financial results for the quarter and half year ended September 30, 2026, and to consider shifting the company's registered office, has been postponed due to unavoidable circumstances and rescheduled to Saturday, November 14, 2026.</p>